
Optometry Times chats with Tracy Williams, OD, FAAO, on AMD and low vision's impact on patients' overall health and mental wellness.
Optometry Times chats with Tracy Williams, OD, FAAO, on AMD and low vision's impact on patients' overall health and mental wellness.
Marsha Link, PhD, uses three words—Imagine, Prepare, and Optimize—to encourage women to assess their current leadership journey, strategically plan for advancement, and explore new opportunities for growth and impact in vision care.
Optometry Times chats with Michael Chaglasian, OD, FAAO during this year's Glaucoma 360 meeting in San Francisco, California.
Shan C. Lin, MD, discusses combined minimally invasive glaucoma surgery and its impact on achieving improved intraocular pressure efficacy.
Cecelia Koetting, OD, FAAO, DIPABO chats with Optometry Times about her role with EnVision Summit's new optometry program and the excitement surrounding the event.
Michael Wolber, CEO of OCULUS USA, sits down with host Mile Brujic, OD, FAAO, to wander through Wolber's engineering background, his accidental passion for eye care, and how he envisions OCULUS paving the way for improved patient care.
William Hogue, OD, MS, sat down with Optometry Times to outline what symptoms and risk factors eye care providers should look out for in identifying central serous chorioretinopathy in their patients, as well as what treatment options are available.
Bonnie An Henderson, MD, cofounder of EnVision Summit, sits down with Optometry Times to detail the upcoming event that takes a unique, family-friendly approach to centering diversity in the eye care profession.
The 2024 EnVision Summit will feature a brand-new Optometry Program, co-chaired by Danica Marrelli, OD, FAAO, AAO Dipl, and Cecelia Koetting, OD, FAAO, DipABO.
Robert Weiss, former president and CEO of The Cooper Companies, shares some of the latest optometric schooling developments from Vietnam in his work with Optometry Giving Sight, the Brian Holden Foundation, and Hanoi Medical University.
Damon Dierker, OD, FAAO, shares latest updates in research on sutureless cryopreserved amniotic membrane for moderate-to-severe dry eye with short treatment duration.
Dr Amy Nau outlines her comprehensive strategy for addressing Demodex infestations and explains how she combines therapies to manage multifactorial dry eye disease.
Amy Nau, OD, discusses a challenging case of Demodex infestation in a 32-year-old male suffering from severe anxiety due to Rosacea and Demodex.
Amy Nau, DO, presents another case of Demodex in a female patient, highlighting the multifaceted approach required for successful treatment.
Dr Amy Nau shares a patient case involving a female with Demodex infestation, ultimately treated with lotilaner.
Dr Mile Brujic discusses his EyeCon presentations, which spanned from antibody drug conjugates (ADCs) and their effect on ocular toxicity for patients with cancer to innovations in eye care.
Real-time insights into fluctuations enhance glaucoma care and understanding of vision risk.
Optometry Times sat down with Carla Calizaire, Global Leader of Diversity Inclusion for Johnson and Johnson Med Tech to go in depth about the Vision Made Possible and Sight for Kids campaign.
Dr David Kading explores various treatment options for MGD, including thermal pulsation and light-based therapies such as low-level and intense pulsed light (IPL).
Dr David Kading elaborates on the diagnostic criteria for MGD and provides insights into his interpretation of meibography and meibomian gland expression results.
Dr David Kading shares a patient case of MGD demonstrating gradual improvement through thermal pulsation therapy.
Dr David Kading presents a case of MGD associated with extreme inflammatory reaction.
Bobak Azamian, MD, PhD, sits down with host Mile Brujic, OD, FAAO, to dive into his journey into eye care, the mantel of responsibility he carries as CEO of Tarsus Pharmaceuticals, and what makes him tick.
Learn what's in the pipeline for eSight, as well as hear how their current technology helps patients.
A rapid fire session details what's in the pipeline for ocular surface dryness therapies.
CSF-1 (0.4% pilocarpine HCl), a presbyopia-correcting drop candidate from Orasis, demonstrated consistent pupil restriction, which also suggests neuroadaptation in patients with presbyopia to the drop over time.
Jeffrey J. Walline, OD, PhD, discusses the 2023 AAOpt keynote speech, "Mental Health and Optometry."
Tracy Doll, OD, FAAO, chats about the AAOpt session "Sunny With a Chance of Tears: What's in the Forecast for Ocular Surface Dryness Therapies?"
Shalu Pal, BSc, OD, FAAO, chats about fitting soft, gas permeable, scleral, and hybrid lenses based on her AAOpt ACE course she presented alongside her ACE course, "Multifocal Fitting Tips for Soft, GP, Scleral and Hybrid Lenses," which she presented alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA.
At AAOpt, Nate Lighthizer, OD, presents a variety of lectures and workshops on lasers and their use in optometry.